Pinnacle Wealth Management Advisory Group, LLC Seagen Inc. Transaction History

Pinnacle Wealth Management Advisory Group, LLC

$925 Million
Q1 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	BUY	$191.51 - $216.16 $957 - $1,080	5 Added 0.15%	3,270 $693,000
Q2 2023 Aug 02, 2023	SELL	$187.64 - $206.25 $23,455 - $25,781	-125 Reduced 3.69%	3,265 $628,000
Q1 2023 May 04, 2023	SELL	$127.59 - $203.08 $21,052 - $33,508	-165 Reduced 4.64%	3,390 $686,000
Q3 2022 Nov 09, 2022	BUY	$135.27 - $180.11 $150,149 - $199,922	1,110 Added 45.4%	3,555 $486,000
Q2 2022 Aug 01, 2022	BUY	$108.81 - $179.33 $22,850 - $37,659	210 Added 9.4%	2,445 $433,000

Q1 2022 May 05, 2022	BUY	$119.61 - $157.85 $68,775 - $90,763	575 Added 34.64%	2,235 $322,000
Q4 2020 Feb 03, 2021	BUY	$164.63 - $211.93 $273,285 - $351,803	1,660 New	1,660 $291,000

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Management Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Management Advisory Group, LLC with notifications on news.

Account